Methyl 2,5-Dichloronicotinate → Methyl 5-chloro-2-(3-(3-fluorophenoxy)pyrrolidin-1-yl)nicotinate
Reaktionsgleichung
Cl[C:2]1[N:11]=[CH:10][C:9]([Cl:12])=[CH:8][C:3]=1[C:4]([O:6][CH3:7])=[O:5].[F:13][C:14]1[CH:15]=[C:16]([CH:23]=[CH:24][CH:25]=1)[O:17][CH:18]1[CH2:22][CH2:21][NH:20][CH2:19]1>>[Cl:12][C:9]1[CH:10]=[N:11][C:2]([N:20]2[CH2:21][CH2:22][CH:18]([O:17][C:16]3[CH:23]=[CH:24][CH:25]=[C:14]([F:13])[CH:15]=3)[CH2:19]2)=[C:3]([CH:8]=1)[C:4]([O:6][CH3:7])=[O:5]Komponenten
3
Versuchsvorschrift
The title compound (D95) (250 mg) was prepared according to the experimental procedure described in Description 62 starting from methyl 2,5-dichloronicotinate (241.37 mg, 1.17 mmol) and 3-(3-fluorophenoxy)pyrrolidine (D60) (253 mg, 1.39 mmol).
Quellen und Nachweise
- ORD-Eintrag
- ord-6acf5286cc4f4c5faa2b3998091409ca
- Quelldatensatz
- uspto-grants-2014_09